MEF2A sequence variants in Turkish population.
Myocyte enhancer factor 2 (MEF2) is present in skeletal, cardiac, and smooth muscles and in neurons. MEF2A gene encodes a transcription factor which was on 15q26. The objective was to study the MEF2A gene in patients with premature MI. The control group consisted of 87 subjects who were older than 45 years with no history of cardiovascular disease or MI and no family history of CAD. The premature MI group consisted of 69 patients with documented MI younger than 45 years. No abnormal bands with single strand conformation polymorphism were detected after screening exon 1 through exon 8. This is the first study that detected 145408: T>C polymorphism in intron 10. In both study groups, the rare polymorphism P279L in exon 7, T>C polymorphism in intron 10, and 21-bp deletion in exon 11 of the gene were not found. The data supported the previous studies indicating no association between MEF2A gene and premature MI.
Gulec
Sukru
S
Ankara University Biotechnology Institute, Ankara University School of Medicine, Ankara, Turkey.
Ruchan Akar
Ahmet
A
Akar
Nejat
N
D000328:Adult; D000368:Aged; D006801:Humans; D026161:MADS Domain Proteins / Q000235:genetics*; D064326:MEF2 Transcription Factors; D008875:Middle Aged; D009203:Myocardial Infarction / Q000235:genetics*; D018006:Myogenic Regulatory Factors / Q000235:genetics*; D011110:Polymorphism, Genetic; D014421:Turkey
D026161:MADS Domain Proteins; D064326:MEF2 Transcription Factors; C578035:MEF2A protein, human; D018006:Myogenic Regulatory Factors